Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2022 Earnings Call Transcript

Page 6 of 6

But at this point, we really believe that the best thing for us to invest in is the business that we’re doing in Corcept. And so, we will proceed in that way. Anything changes, I will let you know, of course. Thank you. And so, I want to thank all of you for tuning in this quarter. Hopefully, big progress in the next three months, and look forward to seeing you at that point in time. So, good rest of the week. Thank you.

Operator: This will conclude today’s conference. You may disconnect your lines at this time. Thank you for your participation.

Follow Corcept Therapeutics Inc (NASDAQ:CORT)

Page 6 of 6